Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD. - Wikidata - awgldk - TriplyDB

Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.

Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.

http://www.wikidata.org/entity/Q34667787

about

What have we learned from large population studies of von Willebrand disease?Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project.Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.Laboratory aspects of von Willebrand disease: test repertoire and options for activity assays and genetic analysis.The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.Diagnostic approach to von Willebrand disease Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation Von Willebrand factor is reversibly decreased during torpor in 13-lined ground squirrels.Rapid discrimination of the phenotypic variants of von Willebrand disease.Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.Variability in platelet- and collagen-binding defects in type 2M von Willebrand disease.von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.Perils, problems, and progress in laboratory diagnosis of von Willebrand disease.Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders.Making a diagnosis of VWD.Bleeders, bleeding rates, and bleeding score.An update on type 2B von Willebrand disease.Technological advances in diagnostic testing for von Willebrand disease: new approaches and challenges.Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH.Developments in the diagnostic procedures for von Willebrand disease.Current and emerging approaches for assessing von Willebrand disease in 2016.Thrombosis and von Willebrand Factor.A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen.Diagnostic challenges in patients with bleeding phenotype and von Willebrand exon 28 polymorphism p.D1472H.Evaluation of a rapid von Willebrand factor activity latex immuno assay for monitoring of patients with von Willebrand disease (VWD) receiving DDAVP or VWF replacement therapy.Diagnosis of inherited von Willebrand disease: comparison of two methodologies and analysis of the discrepancies.Clinical and laboratory phenotype variability in type 2M von Willebrand disease.Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination.A comparative evaluation of a new automated assay for von Willebrand factor activity.Advances in the diagnosis and treatment of Von Willebrand disease.Laboratory Testing for von Willebrand Factor Activity by Glycoprotein Ib Binding Assays (VWF:GPIb).FVIII/VWF ratio is not a reliable predictor of VWD in children.Von Willebrand disease in the United States: perspective from the Zimmerman program

P2860

Q30240214-A2D1AA48-A637-48C4-8CE5-543747E86BEC Q30411744-234454C9-B944-4C08-A41C-4631E14E0ED0 Q34185963-33BED900-9F59-409D-A714-435B30AE15C2 Q34750409-3629618D-C749-4C2B-A995-8EE4C0066419 Q34816051-4161F344-43EB-42D6-95F4-230E3109ED62 Q35220634-12157833-E03C-4B14-96EB-B1C4ADF92642 Q35995241-D694C5BB-92D9-44D8-BF9E-BD1A5881CE21 Q36814657-6E002879-9AB5-44A2-8ECE-D898F7850ECF Q36818547-298E0BCC-FC3B-4A70-86CE-081DA9185B00 Q36920458-4DB107DE-8512-4E2F-8E9C-6B80886C886A Q36920462-40B887B4-5873-4702-AE0C-A10A1B6AAD13 Q36944971-54F96161-6635-412F-A15B-327FF93025C2 Q37635167-223F458B-8B7A-424F-9996-CD071723F801 Q37703427-058A18EE-E914-4D16-B8AD-47FB0864D12E Q38020976-12501C0B-0727-4853-859D-B5976C8DDC60 Q38066864-09AFFA37-925F-4715-B15F-878ABA573877 Q38117731-22E49ACA-B6D1-44E1-9166-F7C727301FDE Q38187477-3DACA177-2789-47DD-8D38-A7E157DD2009 Q38205952-420D9EFF-4386-4AE4-9031-CC6AD8CAD6C5 Q38413638-300B0935-B0EB-419E-BFF9-2A80DA13557F Q38682256-EA07D1B4-EC96-4E05-B4B8-E0E8BCA7E851 Q38900004-CF63E2FB-CF41-4192-96B7-9B3B4085A18F Q39390612-9AF332CB-1CF4-4840-A5AB-54ADDE4A3634 Q45856534-75009B04-8DA3-4827-88D1-23A4860CA73C Q45862885-56780008-BD7D-4C99-9310-D2A0521251B8 Q45864439-6F7413E7-7583-42C8-B451-406F5A9A5B63 Q45867275-98EADAD4-554F-4EAA-BDF7-F8F778024EA5 Q45868176-0913D575-B44F-4E5A-81A4-9F5E9298DDC0 Q45877995-BEEEA4A5-82CA-40B7-9FB2-2BECE31CC37C Q45883482-20D66E24-C521-40AA-8AED-ACC67ADBD208 Q47350762-89CBF015-D94A-406D-890A-30D5CF86ABCF Q53113539-9444BE46-12E4-4E3B-B9F1-9FBFDD798626 Q54528863-210D2363-6174-4A1D-A2A8-829731FA134D Q57094780-7D3BFEE5-B4D0-4514-ACD8-79486A1AE48D

P2860

Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.

http://www.wikidata.org/entity/Q34667787

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Gain-of-function GPIb ELISA as ...... r and Clinical Biology of VWD.

@ast

Gain-of-function GPIb ELISA as ...... r and Clinical Biology of VWD.

@en

Gain-of-function GPIb ELISA as ...... r and Clinical Biology of VWD.

@nl

type

label

Gain-of-function GPIb ELISA as ...... r and Clinical Biology of VWD.

@ast

Gain-of-function GPIb ELISA as ...... r and Clinical Biology of VWD.

@en

Gain-of-function GPIb ELISA as ...... r and Clinical Biology of VWD.

@nl

prefLabel

Gain-of-function GPIb ELISA as ...... r and Clinical Biology of VWD.

@ast

Gain-of-function GPIb ELISA as ...... r and Clinical Biology of VWD.

@en

Gain-of-function GPIb ELISA as ...... r and Clinical Biology of VWD.

@nl

P1433

Q34667787-82F683E0-E44C-4EA3-B6EE-9AB3282C8F17

P1476

Q34667787-04BE129B-9FA4-4C93-B07D-B72A005C3633

P2093

Q34667787-1C3C57CB-9149-4EFA-B789-81FD8F2D25DA

Q34667787-4167BA4D-9E93-4BD7-B7F2-A590815AD233

Q34667787-7E4EA26B-6540-44D9-B26A-440D956B5283

Q34667787-8A05E329-5424-4280-AE6C-97119328CE52

Q34667787-9CEE87D0-5CC4-4BFD-A50D-C3FAF389C3F6

Q34667787-A17C801E-FAB5-4536-9E5B-956C65D4D5B9

Q34667787-C666C7FF-F366-46B3-A5A1-6B2C4C4944C6

Q34667787-FDD5CFCD-B07D-44AB-B2B8-EA4CF70D6AB0

P2860

Q34667787-0D769CBD-608B-4865-B501-0B9D855727E5

Q34667787-1609F7F9-4A04-43BD-98BC-6A82D35892D6

Q34667787-1ABFD448-059D-4685-9951-46E10C1EB78C

Q34667787-1DFE6F92-6506-496C-9F90-CD5BE6D8AD7F

Q34667787-1FDC7F9A-72B4-4938-974A-F20B2AC7C3C0

Q34667787-3222CA3E-AA1A-4768-8D18-97204C2534B5

Q34667787-3790CB43-0DA3-4398-8EE3-BDFDB7DEB941

Q34667787-39B68EE0-1EBA-4CB6-9B90-9ED147EF9D6C

Q34667787-400478D9-D96B-47F5-82E1-5FE1E21D024A

Q34667787-423F6C1C-13E0-43C8-9219-97A2AEC0F2B7

P304

Q34667787-64A51A81-EEC9-4BA7-BCA1-B63E5B2D318F

P31

Q34667787-DA6DE489-41A5-4F9D-AF79-E7442C823187

P356

Q34667787-6EE11C95-0062-4115-9E6F-273C5860CE9C

P407

Q34667787-8C26F398-6B02-41FA-99B5-02BCEECBE585

P433

Q34667787-17DA85B4-A1FF-4D19-B250-6B2EFFB81CC1

P478

Q34667787-653CE3BF-B1B9-43ED-AE01-D7D0044B0AA5

P577

Q34667787-D77EBF78-5C99-4B70-B5AB-7119E0A5D8BB

P5875

Q34667787-1BDDA08A-CBBA-40C5-B607-0E06BAD498A8

P698

Q34667787-DDFF7AA2-D8F5-4574-992E-9485647BC7C7

P932

Q34667787-BE7E2F5B-025D-4845-921F-0B935E194826

P356

BLOOD-2010-08-299016

P1433

P1476

Gain-of-function GPIb ELISA as ...... r and Clinical Biology of VWD.

@en

P2093

Joan Cox Gill

http://www.w3.org/2001/XMLSchema#string

Kenneth D Friedman

http://www.w3.org/2001/XMLSchema#string

Pamela A Christopherson

http://www.w3.org/2001/XMLSchema#string

Patricia A Morateck

http://www.w3.org/2001/XMLSchema#string

Raymond G Hoffmann

http://www.w3.org/2001/XMLSchema#string

Robert R Montgomery

http://www.w3.org/2001/XMLSchema#string

Sandra L Haberichter

http://www.w3.org/2001/XMLSchema#string

Veronica H Flood

http://www.w3.org/2001/XMLSchema#string

P2860

Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain

Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease

Cloning of the alpha chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich alpha 2-glycoprotein

Type 2B von Willebrand's disease due to Val1316Met mutation. Heterogeneity in the same sibship.

A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B.

The A/T1381 polymorphism in the A1-domain of von Willebrand factor influences the affinity of von Willebrand factor for platelet glycoprotein Ibalpha.

Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients.

Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.

P304

e67-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2010-08-299016

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49674667

http://www.w3.org/2001/XMLSchema#string

P698

21148813

http://www.w3.org/2001/XMLSchema#string

P932

3056647

http://www.w3.org/2001/XMLSchema#string